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Abstract 
Background:   
Hemodynamic stability of patients during dialysis sessions is of pivotal importance in 
daily practice and accurate determination of dry weight (DW) remains a challenge.  
Little information is available about central venous and aortic pressure during 
dialysis.  In this pilot study we used a new non-invasive technique to describe the 
changes in central venous pressure (CVP) during dialysis. 
Methods:  An ultrasound-assisted silicon-based pressure-manometer was used at the 
contralateral cephalic vein during haemodialysis to quantify central venous pressure.  
Central aortic pressure changes were assessed as aortic augmentation index (AIx) 
and subendocardial viability ratio (SEVR) by radial applanation tonometry and 
brachial arterial blood pressure measurements.  Bioimpendance was applied to 
measure total body water (TBW), as well as extracellular (ECW) and intracellular 
(ICW) water before and after HD.  All measurements were performed prior during and 
after one and two hours on HD except for bioimpedance that was only assessed 
before and after dialysis.  
Results: Ten patients (5 female) were included with a median age of 72 years (23-
82).  Haemodialysis reduced the weight by 2.0 kg (range 0.2 – 3.9 kg), corresponding 
to a measured decrease in TBW of 1.9 L (36.1 L to 34.2 L, n.s.).  The mean CVP 
showed a significant decrease (9.0 cmH2O to 0.8 cmH2O; p=0.0005) during dialysis.  
The major and significant drop in CVP was found during the first hour of 
haemodialysis (9 cmH2O to 2.8 cmH2O). Starting and stopping dialysis was reflected 
by a reduction of 2.6 cmH2O and a rise of 2.8 cmH2O (n.s.).  AIx decreased 
continuously from 26.1 % to 21.0 % (n.s.).  SEVR increased significantly from 126 % 
to 156 % (p<0.05) during HD, and decreased to 139% direct after HD (n.s.).  
Conclusions: This is the first study that illustrates a prominent reduction of central 
venous pressure during the first hour of hemodialysis. Non-invasive central venous 
pressure measurement is feasible during hemodialysis and adds another piece in the 
puzzle of factors involved in hemodynamic stability    
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Introduction 
Need for renal replacement therapy has increased significantly during the last 30 
years in most parts of the world, and the incidence and prevalence of dialysis 
dependent patients is expected to rise further.1-3  The haemodialysis population has 
changed significantly, with a prominent increase in elderly, diabetic and concomitant 
atherosclerotic diseased patients.2  Therefore the range of tolerated fluid changes 
during haemodialysis in this frail patient population is small and the definition of dry-
weight becomes increasingly important.4  Fluid overload results in pulmonary 
symptoms and left ventricular hypertrophy, whereas fluid deficiency on the other 
hand results in hypotension, which not only leads to severe symptoms during dialysis 
but also promotes heart ischemia resulting in heart failure.5  Hypotensive episodes 
during haemodialysis as well as overhydration are associated with increased 
mortality due to cardiovascular events.6, 7 The “dry-weight” is defined as the body 
weight to be reached at the end of dialysis..8 In daily practice nephrologists rely on 
the symptoms described by the patient and the clinical examination, also these 
subjective information do not perform well in defining fluid overload.4, 8  
Dialysis patients have a particularly high cardiovascular risk and heart failure is very 
common. The major causes of morbidity and mortality in patients with end-stage 
renal disease (ESRD) are cardiovascular diseases9.  An increased aortic stiffness is 
known to be a strong independent predictor of all-cause and mainly cardiovascular 
mortality.10, 11  In contrast to the increasing number of hemodialysis sessions 
performed, little information is available about central venous pressure and aortic 
stiffness as factors which might be involved in patient stability and might help to 
define "dry weight". 
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A novel, ultrasound based method to measure CVP non-invasively recently has been 
introduced.12 Peripheral venous pressure at the forearm is quantified by compression 
of the vein under ultrasound control. A pressure meter adapted on the ultrasound 
transducer records the pressure needed to compress the vein totally. This method 
showed an excellent correlation with CVP in two controlled studies, comparing 
invasive and non-invasive CVP measurement.12, 13 
We therefore used non-invasive methods to defined acute changes in central venous 
pressure (CVP) and central aortic pressure changes during the course of 
haemodialysis sessions.  
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Methods 
Subjects and study design 
This pilot study with non-invasive cardiovascular monitoring during one 
haemodialysis session in consecutive recruited patients was performed at a tertiary 
referral centre in the dialysis suite. The local ethic committee approved the study (Nr. 
2010-0268/1) and all patients gave written informed consent. This pilot study was 
conducted in compliance with the protocol, the current version of the Declaration of 
Helsinki, and ICH-GCP as well as all national legal and regulatory requirements. 
Exclusion criteria were severe arterial hypertension or hypotension and unsuitable 
superficial veins of the forearm or known subclavian vein obstruction (contralateral to 
haemodialysis access) or cardiac arrhythmias that made pulse wave analysis 
impossible. 
Non-invasive measurements of vascular parameters 
Measurements of CVP using compression ultrasound were performed with a high-
end duplex system iU22 with a 17-5 MHz linear array transducer (Philips, Best, 
Netherlands) by a single experienced investigator at the forearm contralateral the 
vascular access site. A pressure manometer (PPM0310, U. Baumann, Muensingen, 
Switzerland) was attached to the ultrasound transducer 14. The manometer consists 
of a translucent silicon membrane (MVQ, Angst and Pfister AG, Zurich, Switzerland) 
connected to a commercially available pressure meter (Bourdon Haenni AG, 
Jegenstorf, Switzerland) with a flexible pressure tubing. The system is described in 
detail elsewhere12, 13.  A superficial vein at the forearm (preferentially the distal 
cephalic vein), clearly visible on ultrasound through the translucent manometer 
membrane was selected. The vein had to be easily compressible, without A
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postphlebitic changes locally and no overt clinical signs of proximal venous 
obstruction had to be present.  After applying ultrasound transmission gel the 
transducer with the pressure meter was placed on the skin with minimal pressure.  
Following zero adjustment slowly increasing pressure was applied by the transducer 
until first complete compression of the vein. The pressure at this collapse point 
indicated the intravasal peripheral venous pressure. The point of measurement was 
below the level of the right atrium. The difference between the level of the ultrasound 
measurement and the position of the right atrium was documented and subtracted 
from the crude pressure value12. 
Bioimpendance analysis was performed before and after haemodialysis using the 
Body Composition Monitor BCM (Fresenius Medical Care, Bad Homburg, Germany) 
to assess total body water (TBW), as well as extracellular (ECW) and intracellular 
(ICW) water15.  
Systolic (BPs) and diastolic blood pressure (BPd), heart rate (HR), CVP, AIX and 
subendocardial viability ratio (SEVR) as a marker of subendocardial perfusion were 
measured before, direct after start of HD (within five minutes), after one and two 
hours, and direct before and after end of haemodialysis (each within five minutes). 
Applanation tonometry of the radial artery was performed in the non-fistula arm with 
the SphygmoCor system (AtCor Medical, Sydney, Australia) by a single observer with 
patients in the supine position to acquire radial artery waveforms. A validated transfer 
function was used to generate the corresponding ascending aortic pressure 
waveform. Augmented pressure was defined as the difference between the second 
and the first systolic peak, and augmentation index (AIX) was expressed as a 
percentage of the pulse pressure (difference between systolic and diastolic 
pressure)16, 17. Subendocardial blood supply as a parameter evaluating the risk of 
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myocardial ischemia was expressed with the subendocardial viability ratio (SEVR), 
the ratio of the diastolic phase (diastolic time index) to that of the systolic phase (time 
tension index) as measured by the SphygmoCor system18-20. 
For statistical analysis StatView (SAS institute Inc.) was used. A p < 0.05 was 
referred to statistically significant. All values represent means (± standard deviation). 
ANOVA was used to compare the means of the measurements before, during and 
after HD. Fisher PLSD (Protected Least Sig. Difference) test was used to test the 
differences of pairwise combinations. 
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Results 
Ten patients (5 female) were included in this feasibility study (table 1). The mean age 
was 61 years (range: 23-82 years). All patients underwent chronic thrice-weekly HD 
and were on haemodialysis for a mean of 28.4 months (range: 2-66 months). 
Clinically, in none of the patients a necessity of a change of the "dry weight" was 
expected by the nephrologist.  
The changes in the measured parameters before and after HD are summarized in 
table 2. Systolic blood pressure decreased from 142 (± 20) to 132 (± 28) mmHg as 
well as the diastolic blood pressure from 66 (± 23) to 62 (± 16) mmHg. Heart rate 
rose from 72 (± 8) to 74 (± 15) beats/min. These changes in BP and HR were 
statistically not significant.  
Excess water measured by bioimpedance before the start of dialysis was well 
controlled with a mean of +1.5 L (table 2). In only two patients the excess water 
exceeded 2 L. The ultrafiltration during the haemodialysis sessions reduced the 
mean body weight by 2.0 (range 0.2 – 3.9) kg. This was consistent with a decrease in 
total body water (TBW) of 1.9 L (36.1 ± 7.4 L to 34.2 ± 5.0 L, n.s.) measured by 
bioimpedance spectroscopy. About 2/3rd of water was from the extracellular 
compartment (ECW 1.1 L, from 16.4 ± 3.4 L to 15.3 ± 3.1 L, n.s.) and about 1/3rd 
from the intracellular water (ICW 0.8 L, from 19.7 ± 5.0 L to 18.9 ± 2.8 L, n.s.). Also 
well correlated with the expected reduction in water, according to body weight, the 
differences did not reach the level of significance.  
Mean CVP showed a significant decrease during dialysis (9.0 cmH2O to 0.8 cmH2O; 
p=0.0005, Figure 1). To measure the effect of the extracorporal blood circulation, the A
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CVP was measured before and immediately after the start of dialysis. Also treatment 
was started with the lines filled with substitute solution, the CVP showed an early 
drop of 2.6 cmH2O (n.s.) and a similar increase after the return of the blood to the 
patient with a mean increase in CVP of 2.8 cmH2O (n.s.). After one hour of dialysis 
the CVP was already significantly lower than the CVP before the start of dialysis (9.0 
vs 2.8 cmH2O, p<0.05). Thereafter, CVP demonstrated a steady decline over the 
following hours with a relatively moderate delta of 1 in the second hour and 0.5 per 
hour during the last two hours.  
AIx decreased continuously from 26.1 % to 21.0 % which did not reach the level of 
significance (n.s.; Figure 2). SEVR increased significantly from 126 % to 156 % 
(p<0.05) during HD (Figure 3), and decreased again to 139% direct after HD (n.s.). 
A
cc
ep
te
d 
A
rti
cl
e
cHemodynamic changes during haemodialysis 
10 
This article is protected by copyright. All rights reserved. 
 
Discussion 
The present study is the first simultaneous evaluation of changes in central venous 
and arterial pressures using non-invasive approaches to investigate the effect of the 
continuous volume ultrafiltration during a four hour haemodialysis session. The 
novelty and primary goal of this pilot study was to demonstrate the feasibility of non-
invasive evaluation of central venous pressure during dialysis. There is a scarcity of 
data on central venous pressure in patients during hemodialysis.  The dry weight of 
the study population was well selected with a moderate water excess before dialysis 
of 1.5 L measured by bioimpedance. The ultrafiltration led to a mean decrease in 
body weight of 2 kg.  This was associated a decrease in CVP from from 9 to 1 
cmH2O. In contrast to the continues ultrafiltration, CVP demonstrated a strong and 
statistically significant decrease within the first hour. With the start of the 
extracorporal circuit CVP decreased rapidly. This is interesting as the lines were filed 
before connecting the patient. The main CVP drop was detectable during the first 
hour and then there was a continuous decrease during the last three hours. The 
prominent decrease of CVP during the first hour of dialysis needs further evaluation. 
It will be particularly interesting whether this decrease in CVP is associated with 
hemodynamic instability and whether this early drop can also be seen in 
overhydrated patients. The bioimpedance measurements particularly the excess 
water did not correlate with the absolute numbers of CVP and with the change in 
CVP most likely due to the low number of patients included in our feasibility study. 
These results will form the basis for the necessary patient number for a currently 
planned study. 
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The aortic augmentation index is a reflection of aortic stiffness and can be calculated 
by the wave form of a peripheral artery.  In our series the AIx demonstrated a trend 
towards a decrease in stiffness during a four hour dialysis session. This is consistent 
with previously published data.21, 22 A significant (p < 0.001) decrease of AIx before 
dialysis from 30.6 ± 1.5 to 22.2 ± 1.8 after dialysis was demonstrated in 51 dialysis 
patients.21 In another study with 20 patients dialysis decreased AIX from 24.2 ± 11.3 
to 15.6 ± 12.6 (p < 0.05) with a similar continuous trend in decrease within the four 
hours dialysis.22 The impact of volume overload on changes in aortic stiffness in 
patients with haemodialysis is incompletely understood. In one study arterial stiffness 
was independently related to the extracellular water / total body water ratio.23  
Volume reduction with dialysis was significantly correlated with a decrease in AIx in 
nineteen patients studied before and 24 h after dialysis.24 In contrast, another study 
reported a high correlation of the improvement in aortic stiffness with decrease in 
systolic blood pressure but not with ultrafiltration volume.22 In addition to AIx, 
subendocardial viability ratio (SEVR) can be calculated through pulse wave analysis 
alike and is an interesting non-invasive measure of myocardial perfusion related to 
left ventricular work. For both parameters, previous studies have shown that pulse-
wave analysis has a good reproducibility in patients with chronic renal failure.25, 26 
There are studies on different modes of haemodialysis and their having dissimilar 
impacts on markers of arterial stiffness. This might have clinical impact since aortic 
augmentation index has been shown to be an independent predictor for 
cardiovascular morbidity in patients with chronic renal failure10.  
During recent years new techniques have been used for the equation of "dry weight" 
.27-29 Particularly the role of bioimpedance spectroscopy found a lot of attention27, 30. 
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We now demonstrate that peripheral measurement of central venous pressure is 
feasible during dialysis and gives additional information. This small pilot study forms 
the basis for the evaluation of the central venous pressure in a larger cohort of 
patients on hemodialysis to define the associations with dry weight and 
hemodynamic stability.   
 
 
 
Conclusions 
Fluid elimination during dialysis as reflected by the difference in weight is confirmed 
by bioimpedance analysis and reduction in central venous pressure. Central venous 
and arterial pressures show early reduction during the first hour which is 
accompanied by a steady improvement in subendocardial perfusion in relation to 
cardiac workload. Whether this new tool will help to define dry weight or preventing 
the early drop might reduce intradialytic hypotension needs to be evaluated in a 
larger population of haemodialysis patients. 
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Figure legends 
Figure1: 
Course of central venous pressure (CVP) before, during and after haemodialysis 
Figure 2: 
Course of augmentation index (AIx) before, during and after haemodialysis 
Figure 3: 
Course of subendocardial viability index (SEVR) before, during and after 
haemodialysis A
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Tables 
 
Table 1: Basic clinical information of the study cohort 
Variable  
n 10 
Female/male 5/5 
Age (years; median; range) 72.5 (23-82) 
HD duration (months; median, range) 28.4 (2-66) 
Height (cm; median; range) 163 (153-172) 
Weight (kg; median; range) 68 (51-95) 
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Table 2: Changes in clinical and hemodynamic parameters before and after 
haemodialysis 
 
Variable before HD after HD p 
Height [cm] 163.5 ± 6.0   
Weight [kg] 68.3 ± 13.9 66.3 ± 13.9 n.s. 
BMI [kg/m2] 25.5 ± 4.5 24.7 ± 4.5 n.s. 
TBW [L] 36.1 ± 7.4 34.2 ± 5.0 n.s. 
ECW [L] 16.4 ± 3.4 15.3 ± 3.1 n.s. 
ICW [L] 19.7 ± 5.0 18.9 ± 2.8 n.s. 
BPs [mmHg] 143 ± 20 132 ± 28 n.s. 
BPd [mmHg] 66 ± 23 62 ± 16 n.s. 
Heart rate [beats/min] 72 ± 8 74 ± 15 n.s. 
CVP [cmH2O] 9.0 ± 7.2 3.6 ± 4.8 * < 0.05 
AIx [%] 26.1 ± 12.2 21.0 ± 6.1 n.s. 
SEVR [%] 126.2 ± 21.4 139.2 ± 31.6 n.s. 
 
Values in mean ± standard deviation 
BMI: body mass index, TBW: total body water, ECW: extracellular water, ICW: 
intracellular water, BPs: systolic blood pressure, BPd: diastolic blood pressure, CVP: 
central venous pressure, AIx: augmentation index, SEVR: subendocardial viability 
index. 
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Figures 
Figure 1 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Course of central venous pressure (CVP) before, during and after haemodialysis 
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Course of augmentation index (AIx) before, during and after haemodialysis 
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Course of subendocardial viability index (SEVR) before, during and after 
haemodialysis 
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